Today: 22 June 2026

Ford (F) Stock Surges on Earnings – Rally Faces EV & Recall Challenges

Ford (F) Stock Surges on Earnings – Rally Faces EV & Recall Challenges

Ford shares jumped 10% after Q3 earnings beat forecasts, closing near a one-year high at around $13. Revenue hit $50.5 billion, up 9% year-over-year, but the company cut 2025 profit guidance by up to $2 billion due to a supplier fire. Ford’s EV unit continues to post losses, and the automaker faces record recalls and higher labor costs. The dividend resumed at $0.15 per share, with most analysts rating the stock a “Hold.”
Explosive Rally and Volatility: Bitcoin’s Surge Propels Bitfarms Stock

Explosive Rally and Volatility: Bitcoin’s Surge Propels Bitfarms Stock

Bitfarms Ltd. (NASDAQ: BITF) stock surged from about $1 in January to over $6 in mid-October 2025, before dropping nearly 40% and rebounding to around $4.90 by Oct. 27. The company raised $588 million in convertible notes to fund a new Pennsylvania data center and expand into AI infrastructure. Bitfarms also announced a CFO transition and moved its headquarters to the U.S. Analyst targets remain mixed amid ongoing losses.
TeraWulf (WULF) Stock Skyrockets 100% on Google-Backed AI Bet – Clean-Energy Bitcoin Miner Takes Off

TeraWulf (WULF) Stock Skyrockets 100% on Google-Backed AI Bet – Clean-Energy Bitcoin Miner Takes Off

TeraWulf shares surged 17% on Oct. 28, 2025, after announcing a $9.5 billion, 25-year joint venture with Fluidstack and Google to build a 168 MW AI compute campus in Texas. The stock pulled back 9% the next day, closing near $14.50. Year-to-date, WULF is up about 117%. Q3 revenue was pre-announced at $42 million, up 84% year-over-year, with full results due Nov. 10.
Sprouts Farmers Market Stock Plunges 25% on Mixed Q3 Earnings – Analysts Scramble

Sprouts Farmers Market Stock Plunges 25% on Mixed Q3 Earnings – Analysts Scramble

Sprouts Farmers Market shares plunged 25% to near $82 on Oct. 30 after Q3 revenue missed estimates and management cut its Q4 sales outlook. Net sales rose 13% to $2.20 billion and EPS beat forecasts, but Q4 comparable-store growth was guided to just 0–2%. UBS and BMO lowered price targets, citing slowing momentum. The stock’s technical indicators showed severe oversold conditions.
Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter shares fell about 16% to $19 on Oct. 30 after cutting its 2025 outlook and missing Q3 sales forecasts. Q3 revenue rose 5% to $2.84 billion, but sales missed estimates; adjusted EPS of $0.69 beat expectations. The company halted Novum IQ infusion pump shipments after two patient deaths and reported hurricane-related supply disruptions. Andrew Hider became CEO in July.
30 October 2025
Guardant Health (GH) Stock Rockets on Earnings Beat and New Cancer-Screening Wins

Guardant Health (GH) Stock Rockets on Earnings Beat and New Cancer-Screening Wins

Guardant Health shares soared nearly 30% to around $94 on Oct. 30, 2025, after Q3 revenue jumped 39% to $265.2 million, beating estimates. The company raised its 2025 revenue outlook to $965–970 million. New partnerships are expanding access to its Shield colorectal cancer test nationwide. Guardant360 received additional FDA approvals and a formal review submission.
Record-Breaking Rally after Trump-Xi Trade Truce – What It Means

Record-Breaking Rally after Trump-Xi Trade Truce – What It Means

Presidents Trump and Xi agreed Oct. 30 to a one-year pause in their tariff war, with China delaying rare-earth export controls and resuming U.S. soybean and energy purchases. The U.S. will cut some tariffs, including halving its fentanyl-related levy. Global stocks hit records ahead of the deal, but markets turned cautious after the announcement. Major issues like tech sanctions and Taiwan remain unresolved.
China–Russia Mega Trade Deal Jolts Markets: Stocks React to New Pact

China–Russia Mega Trade Deal Jolts Markets: Stocks React to New Pact

Russia’s parliament ratified a new investment and trade treaty with China on Oct. 27, including the Power of Siberia-2 gas pipeline memorandum and plans to settle more trade in yuan and rubles. China’s Shanghai Composite and Hong Kong’s Hang Seng fell, while Russia’s MOEX rose. Bilateral trade reached $244.8 billion in 2024 but dropped 9% in early 2025. Oil and gold prices climbed following the announcement.
CVU Stock Skyrockets 70% on Missile Contract Win – CPI Aerostructures Surges as Analysts Weigh In

CVU Stock Skyrockets 70% on Missile Contract Win – CPI Aerostructures Surges as Analysts Weigh In

CPI Aerostructures shares surged up to 75% intraday on Oct. 30 after announcing a major missile wing contract with Raytheon. The stock traded around $3.50–$3.70 by late morning, reversing from 52-week lows earlier in the week. The new order expands CPI’s presence in missile systems, with deliveries starting in 2026. Financial terms were not disclosed.
Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Shares of Medical Properties Trust closed near $5.00 on Oct. 30, 2025, up 3–4% after Q3 earnings beat expectations, valuing the company at $3 billion. Management authorized a $150 million share buyback and reported improved rent collections. The REIT pays a quarterly dividend of $0.08 per share after recent cuts. Short interest remains high at 37% of float, while institutional ownership stands at 58%.
30 October 2025
Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

Harvard Bioscience shares fell to $0.40 in October 2025, down 84% year-over-year, after hitting a 52-week low of $0.28. Nasdaq granted a 180-day extension to regain $1 compliance, and the company is considering a reverse split. Q2 revenue dropped 12% to $20.5 million, but cash flow improved. Debt refinancing is required by December 2025, and John Duke became CEO in July after Jim Green’s retirement.
Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle shares closed near $269 on Oct. 30, down from September highs but up 70% year-to-date as AI/cloud deals fueled gains. Q1 FY26 revenue rose 12% to $14.93 billion, with cloud sales up 28%. Reports cite major unconfirmed deals with OpenAI and Meta, driving RPO to $455 billion. Analyst targets cluster around $320–$400, but Oracle’s valuation remains high compared to rivals.
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia Stock Rockets to $5 Trillion Valuation – AI Frenzy Fuels Record Highs

Nvidia became the first U.S. company to surpass $5 trillion in market value on Oct 29, closing at $207.04 per share. The stock pulled back about 1.4% to $204–$205 on Oct 30. Year-to-date, Nvidia shares are up roughly 50%, driven by surging AI chip demand and major deals with OpenAI and the U.S. Department of Energy. Rival AMD also announced a large AI chip deal with OpenAI.
Chinese EV Tsunami Shakes German Auto Industry: BYD’s 30% Profit Crash and ‘Electrobomber’ Fears

Chinese EV Tsunami Shakes German Auto Industry: BYD’s 30% Profit Crash and ‘Electrobomber’ Fears

BYD’s Q3 profit fell nearly 33% year-on-year to ¥7.8 billion, as revenue dropped 3% amid a price war in China. Despite shrinking domestic margins, BYD’s European new-car registrations in September 2025 jumped nearly fivefold, while Tesla’s fell 10.5%. Chinese automakers’ share of EU new-car sales nearly doubled to 4.8% in early 2025, pressuring German brands.
30 October 2025
Plug Power’s 170% Hydrogen Rally Cools – Can PLUG Stock Reignite?

Plug Power’s 170% Hydrogen Rally Cools – Can PLUG Stock Reignite?

Plug Power shares soared about 170% from late summer lows to a $4.58 peak in early October, then dropped to around $2.8–$2.9 by Oct. 30. The company signed a 2 GW electrolyzer deal in Uzbekistan, raised $370 million, and secured major credit lines. Founder CEO Andy Marsh will step down in 2026. Analysts remain split, with targets ranging from $1 to $4.50.
Intel (INTC) Stock Soars 90% to 18-Month High on AI Boom, $15B Lifeline – Will the Rally Last?

Intel (INTC) Stock Soars 90% to 18-Month High on AI Boom, $15B Lifeline – Will the Rally Last?

Intel stock has surged 85–90% year-to-date, hitting an 18-month high near $42 after a surprise Q3 return to profit and $13.7 billion in revenue. The U.S. government, Nvidia, and SoftBank invested $15 billion in 2025, with Washington taking a 10% stake. New CEO Lip-Bu Tan is steering Intel toward AI and advanced manufacturing. Analysts warn the stock’s valuation, now ~70× forward earnings, far exceeds peers.
Ambev’s Profit Soars 36% in Q3 – Buyback Announced as ABEV Stock Eyes Rally

Ambev’s Profit Soars 36% in Q3 – Buyback Announced as ABEV Stock Eyes Rally

Ambev S.A. reported Q3 net income of 4.86 billion reais, up 36% year-on-year and well above analyst forecasts. Beer volumes fell 5.9%, but higher prices kept revenue flat; EBITDA was R$7.06 billion, beating estimates. The board approved a buyback of up to 208 million shares. Shares traded around $2.25 after results, with analysts split on outlook amid sector headwinds.
BYD’s European EV Invasion – Boom in Sales but Stock Takes a Hit

BYD Stock Plunges 30% on Profit Slump – Is the EV Price War to Blame?

BYD reported a 32.6% drop in Q3 net profit to ¥7.8 billion and cut its 2025 sales target by 16% on Oct. 30. The Hong Kong stock slid to HK$104.20, down about 30% from May highs, erasing over $45 billion in market value. Q3 deliveries in China fell for the first time since 2020 amid fierce EV price competition. Overseas, BYD registrations in Europe surged nearly fivefold in September.

Stock Market Today

  • NuScale Power Stock Near Lows Amid Small Modular Reactor Growth Prospects
    June 21, 2026, 7:09 PM EDT. NuScale Power (NYSE: SMR) remains near its yearly low around $12, despite holding the only small modular reactor (SMR) design approved by the U.S. Nuclear Regulatory Commission. SMRs, compact nuclear reactors with flexible site placement, are gaining attention as a potential game-changer in electricity generation. NuScale's regulatory lead and recent 6 GW deployment deal with Tennessee Valley Authority highlight growth potential, though commercial operations and revenue remain years away. The stock's volatility between $8 and $57 reflects high uncertainty in this pre-revenue phase. Analysts advise a long-term investment horizon of 10 years or more, recommending small portfolio positions due to risks in regulatory processes and project timelines. Investors face a balanced risk-reward scenario with upside tied to the pace of SMR commercial adoption.

Latest articles

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

22 June 2026
Cognizant shares plunged 10.49% to $43.70, erasing $2.4 billion in equity value—more than its $2 billion 2026 buyback target—after Accenture’s narrowed growth outlook, a Berenberg downgrade, and looming Nasdaq-100 removal, even as S&P 500 and Nasdaq rallied; investors now eye Q2 guidance as the next key test.
Pentagon Could Outpace Tech Giants on Small Nuclear Projects

Pentagon Could Outpace Tech Giants on Small Nuclear Projects

22 June 2026
Valar Atomics’ Ward 250 became the first DOE-authorized advanced reactor built outside a national lab to achieve criticality, signaling a shift as U.S. defense demand accelerates small nuclear deployment, with the Army allocating over $2 billion for microreactors—moving the sector from policy to production and raising near-term demand expectations.
Go toTop